Current disease status-First occurrence of the cancer - Page 2 of 58 Posts on Medivizor
Navigation Menu

Current disease status-First occurrence of the cancer Posts on Medivizor

FOLFIRINOX before pre-surgery treatment can improve the outcomes of patients with rectal cancer

FOLFIRINOX before pre-surgery treatment can improve the outcomes of patients with rectal cancer

Posted by on Jun 6, 2021 in Colorectal cancer | 0 comments

In a nutshell The aim of this study was to investigate FOLFIRINOX (oxaliplatin, irinotecan, leucovorin, and fluorouracil) before pre-surgery chemoradiotherapy (CRT) for patients with rectal cancer (RC). The study found that FOLFIRINOX given before CRT and surgery improved the outcomes of these patients. Some background RC can be treated with...

Read More

Long-term outcomes of focal cryotherapy in low- to intermediate-risk prostate cancer.

Long-term outcomes of focal cryotherapy in low- to intermediate-risk prostate cancer.

Posted by on Jun 5, 2021 in Prostate cancer | 0 comments

In a nutshell This study looked at the use of focal cryotherapy (FC) for the treatment of low- to intermediate-risk prostate cancer (PC). The authors found that the use of FC was safe and increased time to further therapy with similar survival compared to active surveillance (AS).  Some background PC is one of the most common forms of...

Read More

Does pembrolizumab improve survival of patients with metastatic non-small-cell lung cancer in the long term?

Does pembrolizumab improve survival of patients with metastatic non-small-cell lung cancer in the long term?

Posted by on May 23, 2021 in Lung cancer | 0 comments

In a nutshell This study evaluated the long-term effectiveness of pembrolizumab (Keytruda) in patients with untreated metastatic non-small cell lung cancer (NSCLC). The authors showed that pembrolizumab increased the long-term survival of patients compared to chemotherapy. Some background NSCLC accounts for most lung cancers....

Read More

Should cemiplimab be considered a first-line treatment for advanced non-small-cell lung cancer?

Should cemiplimab be considered a first-line treatment for advanced non-small-cell lung cancer?

Posted by on May 23, 2021 in Lung cancer | 0 comments

In a nutshell This study aimed to examine the effectiveness and safety of cemiplimab (Libtayo) in the first-line treatment of patients with advanced non-small-cell lung cancer (NSCLC) with a high quantity of PD-L1 protein. The study concluded cemiplimab improved survival of these patients compared to standard chemotherapy. Some background NSCLC...

Read More

Updates on the addition of radiotherapy for patients with locally advanced rectal cancer

Updates on the addition of radiotherapy for patients with locally advanced rectal cancer

Posted by on May 23, 2021 in Colorectal cancer | 0 comments

In a nutshell This study reviewed the role of the addition of radiation therapy (RT) for the treatment of locally advanced rectal cancer (LARC). Researchers suggested that radiation therapy during surgery is associated with a lower recurrence (when cancer comes back) rate.  Some background Locally advanced and locally recurrent rectal cancer are...

Read More

Irinotecan plus bevacizumab improves metastatic colorectal cancer outcomes

Irinotecan plus bevacizumab improves metastatic colorectal cancer outcomes

Posted by on May 23, 2021 in Colorectal cancer | 0 comments

In a nutshell This study investigated the best first-line therapy to add to bevacizumab (Avastin) treatment in patients with metastatic (spread to other parts of the body) colorectal cancer (mCRC). Researchers suggested that irinotecan (Camptosar) plus bevacizumab improved the outcomes of these patients. Some background Colorectal cancer is...

Read More

Comparing laparoscopic versus open surgery for patients with rectal cancer.

Comparing laparoscopic versus open surgery for patients with rectal cancer.

Posted by on Apr 25, 2021 in Colorectal cancer | 0 comments

In a nutshell The aim of this study was to compare the outcome of laparoscopic (keyhole surgery) and open surgery for patients with rectal cancer. The study found no difference in patient outcomes between laparoscopic and open surgery groups. Some background Localized rectal cancer can be treated by surgical removal of the tumor. Usually, patients...

Read More

Comparing the effectiveness of different chemotherapy regimens after surgery in early stage breast cancer

Comparing the effectiveness of different chemotherapy regimens after surgery in early stage breast cancer

Posted by on Apr 21, 2021 in Breast cancer | 0 comments

In a nutshell This study compared the effectiveness and safety outcomes of current chemotherapy regimens for treatment in patients with early-stage breast cancer (BC). The data showed that the current treatment regimens have similar effectiveness. Some background BC is classified into different subtypes depending on the presence or...

Read More

Can stereotactic body radiotherapy can be used as an alternative to minimal invasive surgery for early-stage non-small cell lung cancer?

Can stereotactic body radiotherapy can be used as an alternative to minimal invasive surgery for early-stage non-small cell lung cancer?

Posted by on Apr 10, 2021 in Lung cancer | 0 comments

In a nutshell This article compared the use of video-assisted thoracoscopic lobectomy (VATL) versus stereotactic body radiotherapy (SBRT) for the treatment of early-stage non-small cell lung cancer (NSCLC). The authors found that SBRT could provide an alternative treatment option for these patients.  Some background Early-stage NSCLC is...

Read More